Navigation Links
'Neurological work-arounds' offer hope to people with monoamine-related disorders
Date:2/20/2009

Researchers have known for decades that the brain has a remarkable ability to "reprogram" itself to compensate for problems such as traumatic injury. Now, a research article published in the February 2009 issue of the journal Genetics (http://www.genetics.org) suggests that the brain may also be able to compensate for problems with key neurotransmitters such as serotonin and dopamine. This finding may open the doors to entirely new lines of research and treatments for a wide range of brain disorders, including addiction, depression, Parkinson's disease, and schizophrenia.

David Krantz, Associate Professor at the University of California, Los Angeles and Anne Simon, now an Assistant Professor at York College of the City University of New York were the two lead investigators on the study. "Illnesses such as depression, addiction, schizophrenia and Parkinson's disease devastate millions of lives each year. Current treatment strategies often fail and remain poorly understood," said Krantz. "In our research, we have discovered a simple way to identify the functional changes that may be associated with these illnesses and to research new drugs."

To reach this conclusion, Krantz, Simon and colleagues bred fruit flies with what should have been a devastating, life-threatening mutation in the vesicular monoamine transporter gene. This mutation caused their brain cells to be unable to release monoamine neurotransmitters such as serotonin and dopamine. Fruit flies were used in the study because they are convenient for genetic experiments and have a set of neurotransmitters that is nearly identical to that of humans. And as is the case with humans, monoamine neurotransmitters are considered necessary for the fly to function normally. The researchers observed that although the mutant fruit flies crawled less as larvae and were infertile as adults, they lived and were surprisingly healthy in many respects. This
'/>"/>

Contact: Tracey DePellegrin Connelly
td2p@andrew.cmu.edu
412-268-1812
Federation of American Societies for Experimental Biology
Source:Eurekalert

Page: 1 2

Related biology news :

1. Biologists discover link between CGG repeats in DNA and neurological disorders
2. Deranged calcium signaling contributes to neurological disorder, UT Southwestern researchers find
3. MNI researchers locate neurological basis of depression following sports concussion
4. New paper offers key insights into how new species emerge
5. Studies offer guide as protein interaction mapping comes of age
6. UC Davis discovery offers hope for treating kidney cancer
7. International public-private partnership offers new paradigm for medicinal chemistry
8. Rong Li Lab offers insight into adaptive ability of cells
9. New papers offer insights into process of malarial drug resistance
10. Light pollution offers new global measure of coral reef health
11. Ripple effect: Water snails offer new propulsion possibilities

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/23/2009)..., D.C. The community-associated strain of the dea...istant to most common antibioticsposes a far great...ng its way into hospitals, according to a study in...es . , The new threat is easily picked up in fi...d has increased the overall burden of MRSA within ...
(Date:11/23/2009)...lif. -- More than 160 participants gathered this w... FUTURES INITIATIVE conference. This year,s topic,... engineers, and medical researchers to explore the...nding the emerging field of synthetic biology. , ... at Princeton University and this year,s conferenc...
(Date:11/23/2009)... Calif. - By producing some of the highest resolut...es, scientists have a deeper understanding how bio...earch may lead to a new treatment for kidney stone...ars in the Nov. 23 online edition of the journal ...explores how peptides interact with mineral surfac...
Breaking Biology News(10 mins):New study finds MRSA on the rise in hospital outpatients 2Synthetic biology offers new opportunities for interdisciplinary collaboration 2Scientists watch as peptides control crystal growth with 'switches, throttles and brakes' 2Scientists watch as peptides control crystal growth with 'switches, throttles and brakes' 3New Initiative to Improve Mental Health Among Chicago Latinos 52989 1New Initiative to Improve Mental Health Among Chicago Latinos 52989 2New Initiative to Improve Mental Health Among Chicago Latinos 52989 3New Initiative to Improve Mental Health Among Chicago Latinos 52989 4Courage Center Welcomes Susan Oswald as Major Gifts Director 52985 1Courage Center Welcomes Susan Oswald as Major Gifts Director 52985 2Study Shows Cancer Vaccines Led to Long Term Survival for Patients with Metastatic Melanoma and to Long Periods of Disease Control After Completion of 4790 1Study Shows Cancer Vaccines Led to Long Term Survival for Patients with Metastatic Melanoma and to Long Periods of Disease Control After Completion of 4790 2Study Shows Cancer Vaccines Led to Long Term Survival for Patients with Metastatic Melanoma and to Long Periods of Disease Control After Completion of 4790 3
...ed the term "slobber knocker," is there a limit to... handle before the player suffers a concussion" , ...the University of North Carolina at Chapel Hill. H...Carolina football players over the 2004 to 2006 se...l theories about these mild traumatic brain injuri...
...ot of botanical diversity, there are more than 20,...ral thousand of them are used by traditional heale...of problems from the common cold to serious diseas...tments are will be the focus of The International ...), a collaborative research effort between the Uni...
...he United States Department of Agriculture (USDA) ...techniques" used in the production of packaged pro...ue of HortScience, simulated washing techniques to...ality and safety of pre-cut lettuce. , Yaguang Lu...tates Department of Agriculture,s (USDA) Produce Q...
Other Biology News:High-tech helmets reveal new information about the impact of hard hits to the head 2High-tech helmets reveal new information about the impact of hard hits to the head 3High-tech helmets reveal new information about the impact of hard hits to the head 4Study of African traditional medicine will begin world-first clinical trial 2Study of African traditional medicine will begin world-first clinical trial 3Fresh-cut produce washing practices can minimize food-borne illness risks 2
(Date:11/24/2009)...stCall/--Sigma-AldrichCorporation(Nasdaq: SIAL )wi...cember1stat1:45PMGMTinLondon,7:45AMUS/CST.Interest...rnetavailableat http://inve s tor.sig m a a ...ssthisfile. ,, AboutSigma-Aldrich: Sigma-Ald...Itschemicalandbiochemicalproductsandkitsareusedins...
(Date:11/24/2009)...a/--ShanghaiBiolaxyannouncedthe,ChineseStateFood&a...ationalnewdrugapplication(IND)foritsoralinsulinpro...tdiabetes.ThisIND,approvalallowsBiolaxytoinitiatei...rdercharacteristicofhighbloodglucoseandpoor,metabo...micro-and,macro-vasculardiseases,lossofvision,kidn...
(Date:11/24/2009)...irstCall/--Shireplc(LSE:SHP,NASDAQ: SHPGY ),thegl...cedthatithassubmittedaMAAtotheEuropeanMedicinesAge...menttherapyindevelopment,forthetreatmentofType1Gau...velaglucerasealfathathasbeensubmitted,withprevious...edonaglobalsupplyshortageofthecurrentlyapprovedand...
(Date:11/24/2009)...tracts Service (CAS), the global expert on chemica...is now the world,s leading producer of patent inve...an,s patent office, the World Intellectual Propert...t and Trademark Office (USPTO) for more than a dec...nd exceeded Japan for the first time on a monthly ...
Breaking Biology Technology:Biolaxy Secures IND Approval for Oral Insulin 2Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 2Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 3China Leads All Nations in Publication of Chemical Patents According to CAS, the World's Most Authoritative Publisher of Chemical Information 2China Leads All Nations in Publication of Chemical Patents According to CAS, the World's Most Authoritative Publisher of Chemical Information 3
... - Completed Series B Total Stands at EUR21.3 m ... focused on novel therapeutic,and preventative app...oday,announced that Roche Venture Fund and Enterpr...llion to the Series B financing announced in Febru... million. The new investors,join Novartis Venture ...
...lable in French . , An NSERC-funded lab at the U...a lithium battery that can store and deliver more ... ion batteries. , The research team of professor... postdoctoral fellow Kyu Tae Lee are one of the fi...nce for a lithium-sulphur battery. The finding is ...
...8 Charleston Laboratories, Inc., an emerging spec... opioid-induced nausea and vomiting (OINV) in opio...lly completed the Exploratory Bioequivalence Study... "These are promising data on our immediate-relea...ief Operating Officer at Charleston Laboratories, ...
Other Biology Technology:Roche Venture Fund, Enterprise Ireland Commit EUR3.3 M to Opsona Series B Financing 2Roche Venture Fund, Enterprise Ireland Commit EUR3.3 M to Opsona Series B Financing 3Canadian research team reports major breakthrough in lithium battery technology 2Charleston Laboratories, Inc. Completes Exploratory Bioequivalence Study of CL-108 2
... StabilCoat Plus Microsphere/Microarray Stabilizer...ovine protein and other non-toxic chemicals in a P.... This product contains a combination of 0.02% me... preservative. StabilCoat Plus Stabilizer provide...
... The Corning CellBIND surface is produced by a pat...ilic surface giving more consistent, even cell att...D enhances cell attachment and growth uunder diffi...free medium. • CellBIND may provide a more ec...
Mouse Anti-PSD-95, PDZ Domain Monoclonal Antibody, Unconjugated, Clone K28/86.2 from Upstate
... Powerful data acquisition, analysis and experimen...rker data with on-line and off-line analysis. powe...in script language allowing the user to customize ...ns range from basic data logging to complex setups...
Biology Products: